148 related articles for article (PubMed ID: 4740843)
1. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
2. Antibody nature of the long-acting thyroid stimulator.
Földes J; Takõ J; Bãnos C; Gesztesi E
Acta Med Acad Sci Hung; 1971; 28(3):313-9. PubMed ID: 5154552
[No Abstract] [Full Text] [Related]
3. Radioimmunological studies on the long-acting thyroid stimulator.
Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
[No Abstract] [Full Text] [Related]
4. Isoelectric focusing of long-acting thyroid stimulator (LATS) containing IgG.
Schleusener H; Adlkofer F; Uher L; Kaper-Czygan S; Kirstaedter HJ
Horm Metab Res; 1971 May; 3(3):221-2. PubMed ID: 5171402
[No Abstract] [Full Text] [Related]
5. [LATS production by lymphocyte culture].
Fukuchi M
Nihon Naibunpi Gakkai Zasshi; 1969 Oct; 45(7):766-77. PubMed ID: 5394607
[No Abstract] [Full Text] [Related]
6. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
Burke G; Silverstein GE
JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
[No Abstract] [Full Text] [Related]
7. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
8. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
9. Comparative effects of immunization of rabbits with human thyroglobulin and human and rabbit thyroid microsomal fractions.
Beall GN; Chopra IJ; Solomon DH
Clin Exp Immunol; 1971 Apr; 8(4):647-56. PubMed ID: 5576294
[TBL] [Abstract][Full Text] [Related]
10. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
Amino N; Miyai K; Azukizawa M; Kumahara Y
Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
[No Abstract] [Full Text] [Related]
11. Failure of immunologic reaction of long acting thyroid stimulator (LATS) to thyroid components, and the demonstration of a plasma inhibitor LATS.
Burke G
J Lab Clin Med; 1967 May; 69(5):713-27. PubMed ID: 4960804
[No Abstract] [Full Text] [Related]
12. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
[No Abstract] [Full Text] [Related]
13. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
14. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
Mori T; Fisher J; Kriss JP
J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
[No Abstract] [Full Text] [Related]
15. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
Földes J; Takó J; Bános C; Gesztesi E; Juhász J
Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
[No Abstract] [Full Text] [Related]
16. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.
Lonergan C; Babiarz D; Burke G
J Clin Endocrinol Metab; 1973 Mar; 36(3):439-44. PubMed ID: 4631063
[No Abstract] [Full Text] [Related]
17. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
18. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
Furth ED; Dentinger M
Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
[No Abstract] [Full Text] [Related]
19. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
20. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
Zakarija M; McKenzie JM
Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
